A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: The MRC/EORTC QLQ-LEU

Abstract

We describe the psychometric analysis of a supplementary quality of life measure (MRC/EORTC QLQ-LEU) for evaluating long term sequelae of leukaemia treatments. The questionnaire under development was administered to 388 patients entered into the EORTC-GIMEMA AML 8A and the MRC AML10 clinical trials who were in complete remission for at least one year after completion of treatment on these trials. Results indicated a measure which is useful in evaluating the long-term effects of treatment in relation to chronic graft-vs-host disease and infection susceptibility. The performance of this measure in terms of its sensitivity and specificity between treatment arms was established by comparisons between the three treatment modalities in the above-mentioned trials and is the subject of further investigation. The new Leukaemia Module can be recommended for use alongside generic QOL instruments as a measure of long-term quality of life in leukaemia trials.

DOI: 10.1007/BF00435964

3 Figures and Tables

Statistics

0100200'98'00'02'04'06'08'10'12'14'16
Citations per Year

364 Citations

Semantic Scholar estimates that this publication has 364 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Watson1996AMQ, title={A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: The MRC/EORTC QLQ-LEU}, author={Maura I Watson and Robert Zittoun and Elise Hall and Gabriel Solbu and Keith Wheatley}, journal={Quality of Life Research}, year={1996}, volume={5}, pages={15-19} }